CONTURA INTERNATIONAL LIMITED
Controlled by Juno Pharmaceuticals LP, the company manufactures patented hydrogel-based medical products for treatments including urinary incontinence and facial reconstruction.
Get an alert when CONTURA INTERNATIONAL LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£331k
-86.4% lowest in 3 filed years
Net assets
£26m
+24.4% highest in 3 filed years
Employees
134
+11.7% highest in 3 filed years
Profit before tax
£2.2m
+194.2% highest in 3 filed years
Net assets
3-year trend · vs Health Care median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £20,922,650 | £25,050,838 | £35,840,255 | +43.1% | |
| Operating profit | £1,995,590 | £1,104,354 | £4,923,566 | +345.8% | |
| Profit before tax | £523,262 | -£2,303,374 | £2,168,677 | +194.2% | |
| Net profit | £420,981 | -£1,032,808 | £4,356,162 | +521.8% | |
| Cash | £1,246,004 | £2,441,344 | £330,881 | -86.4% | |
| Total assets less current liabilities | £43,772,721 | £51,949,655 | £59,232,785 | +14% | |
| Net assets | £22,298,672 | £20,639,471 | £25,678,614 | +24.4% | |
| Equity | £22,298,672 | £20,639,471 | £25,678,614 | +24.4% | |
| Average employees | 89 | 120 | 134 | +11.7% | |
| Wages | £7,471,407 | £10,110,229 | £12,349,165 | +22.1% | |
| Directors' remuneration | £385,951 | £378,100 | £542,182 | +43.4% | |
| Highest paid director | £356,707 | £347,790 | £510,284 | +46.7% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Operating margin | 9.5% | 4.4% | 13.7% | |
| Net margin | 2.0% | -4.1% | 12.2% | |
| Return on capital employed | 4.6% | 2.1% | 8.3% | |
| Gearing (liabilities / total assets) | 57.8% | 60.3% | 56.6% | |
| Current ratio | 2.28x | 1.40x | 1.40x | |
| Interest cover | 1.06x | 0.20x | 1.17x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Consolidated group
- Auditor
- MHA
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Based on the foregoing these financial statements have been prepared on a going concern basis.”
Group structure
- CONTURA INTERNATIONAL LIMITED · parent
- Contura A/S 100%
- Contura International A/S 100%
- Contura Properties A/S 100%
- Contura Sydmarken 29 A/S 100%
Significant events
- “On 20th February 2025 the Business overdraft facility was increased to DKK 104,500,000 (equivalent to £12,215,650).”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
6 active · 0 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BANKS, Patrick John | Secretary | 2021-01-07 | — | — |
| BANKS, Patrick John | Director | 2021-01-07 | Aug 1962 | British |
| FRASER-PYE, Graham Julian | Director | 2021-01-07 | Mar 1968 | British |
| JACOBSON, Ian | Director | 2021-01-07 | Mar 1960 | Canadian |
| PODOLSKY, Craig | Director | 2021-01-07 | Feb 1981 | Canadian |
| TAILOR, Rakesh Chhaganlal | Director | 2021-01-07 | Mar 1974 | British |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Juno Pharmaceuticals Lp | Corporate entity | Shares 50–75% | 2021-03-01 | Active |
| Contura Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100% | 2021-01-07 | Ceased 2021-03-01 |
Filing timeline
Last 20 of 27 total filings
Material constitutional events — rename, articles re-file, resolution
- 2022-11-14 MA Memorandum articles
- 2022-11-14 RESOLUTIONS Resolution
- 2022-04-28 MA Memorandum articles
- 2022-04-27 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-10-12 | AA | accounts | Accounts with accounts type group | |
| 2026-03-13 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2026-01-08 | AA | accounts | Accounts with accounts type group | |
| 2025-11-28 | SH01 | capital | Capital allotment shares | |
| 2025-01-28 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-01-06 | AA | accounts | Accounts with accounts type group | |
| 2024-09-09 | SH01 | capital | Capital allotment shares | |
| 2024-02-09 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-01-10 | AA | accounts | Accounts with accounts type group | |
| 2023-07-21 | SH01 | capital | Capital allotment shares | |
| 2023-03-30 | SH01 | capital | Capital allotment shares | |
| 2023-03-30 | SH01 | capital | Capital allotment shares | |
| 2023-01-30 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2023-01-08 | AA | accounts | Accounts with accounts type group | |
| 2022-12-01 | SH01 | capital | Capital allotment shares | |
| 2022-11-14 | MA | incorporation | Memorandum articles | |
| 2022-11-14 | RESOLUTIONS | resolution | Resolution | |
| 2022-04-28 | MA | incorporation | Memorandum articles | |
| 2022-04-27 | RESOLUTIONS | resolution | Resolution | |
| 2022-04-26 | SH01 | capital | Capital allotment shares |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 4
- Capital events
- 1
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.